Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 12.97%
- Poor long term growth as Net Sales has grown by an annual rate of 0.20% and Operating profit at 0.36% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 25
3
With ROE of 0.16%, it has a Very Expensive valuation with a 3.07 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.23%
0%
20.23%
6 Months
33.29%
0%
33.29%
1 Year
54.43%
0%
54.43%
2 Years
109.01%
0%
109.01%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Sandoz Group AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
0.36%
EBIT to Interest (avg)
14.19
Debt to EBITDA (avg)
1.71
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
0.80
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
12.97%
ROE (avg)
0.15%
Valuation key factors
Factor
Value
P/E Ratio
1881
Industry P/E
Price to Book Value
3.07
EV to EBIT
18.18
EV to EBITDA
13.72
EV to Capital Employed
2.42
EV to Sales
2.71
PEG Ratio
NA
Dividend Yield
1.23%
ROCE (Latest)
13.32%
ROE (Latest)
0.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
9,121.10
8,940.70
2.02%
Operating Profit (PBDIT) excl Other Income
1,801.80
1,574.40
14.44%
Interest
235.10
177.90
32.15%
Exceptional Items
-10.60
-43.10
75.41%
Consolidate Net Profit
0.90
71.90
-98.75%
Operating Profit Margin (Excl OI)
149.10%
123.30%
2.58%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.02% vs 0.92% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -98.75% vs -91.14% in Dec 2023
About Sandoz Group AG 
Sandoz Group AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






